v2 3rd (11-13 June 2015) KNH and UON Conference-Research as a Driver for Science & Technology...
-
Upload
amos-otieno -
Category
Documents
-
view
130 -
download
0
Transcript of v2 3rd (11-13 June 2015) KNH and UON Conference-Research as a Driver for Science & Technology...
ByAmos Otieno Olwendo
Thesis Research (May 2014), Masters of Science(MSc) in Medical
Informatics04/15/23 1
1.1 INTRODUCTION WHO lists COPD as the 4th leading cause of death
worldwide 90% of COPD mortalities experiences in middle
and low-income countries
COPD diagnosis is prone to under-diagnosis and misdiagnosis (reported in UK, Australia, Canada
e.t.c)
Known risk factors:- Smoking of tobacco, anti-1-trypsin (A1At), and air pollution are the known major risk factors
1.2 Previous Studies? Previous studies have focused on using PFTs Identify COPD phenotypes using variables classify COPD cases based on severity (Stage 1
- 4) with Stage 1 being Mild and Stage 4 Very Severe (Figure 2.1)
Use methods ;data-driven phenotyping techniques such as:- Cluster analysis PCA Factor analysis Discriminant analysis to define COPD phenotypes
04/15/23 Amos Otieno Olwendo 3
1.3 What’s new? Our model attempts NOT to use PFT
Phenotyping is related to disease classification
classifies COPD phenotypes based on Morphology (appearance) Function Behavior
We use a Bayesian Network We achieved a classification of 98.75% on the
test data set
04/15/23 Amos Otieno Olwendo 4
1.4 What’s a COPD Phenotype?
04/15/23 Amos Otieno Olwendo 5
1.5 Phenotypes in action?
04/15/23 Amos Otieno Olwendo 6
1.6 Research Scope1. Determine the essential variables and parameters2. Design the probabilistic model used in this research3. Determine whether a given patient case has COPD4. Identify the consequent COPD Phenotype
4.1 Emphysema4.2 Chronic bronchitis4.3 General COPD (amalgamation of bronchitis and
emphysema)4.4 Asthmatic COPD (amalgamation of asthma and
any other phenotype(s))5. Ascertain whether the given patient has Asthma6. Severity ; NEXT as in Figure 2.17. Determine cause-effect relationships among
variables
7
2.1 LITERATURE REVIEW
8
9
•
10
2.4 Spirometry & Barriers FEV1 decline predicts the future of the
patient Equipment and training costs
Low confidence in the use and interpretation of the results
Perceived lack of utility Quality assurance issues Physical demand from the patient to use
the spirometer – esp. by the elderly and those experiencing respiratory challenges
11
2.5 What is Modeling?research technique that
connects empiricism to theory, and
experiments to theory construction and validation
Here: BN used as the knowledge base laws of probability theory as the reasoning engine
04/15/23 Amos Otieno Olwendo 12
2.6 Why PGMs?1. Ability to handle vagueness as a result of:
i. Biased or incomplete understanding of the event at hand
ii. World of Noisy observationsiii. Phenomena not representediv. Randomness of events in real-life
2. Human reasoning -based on facts and assumptions
3. Probabilistically – degrees of belief are adjustable based on evidence
4. Intuitive with a compact data structure13
2.7 Why BNs?
14
Representation: a directed acyclic graph (DAG) Composed of random variables X1, …, Xn
organized as Query, Non-query, and Evidence variables
Each variable/factor has a corresponding CPT Parent-child relationships of variables are
represented as CPDs [ P(X1, …, Xn) ] Inference: exact and approximate Learning: both parameters & structure, with
complete or incomplete data (through MLE) Employs the use of Chain rule for BN
Knowledge Engineering Knowledge acquisition
-elicitation, -collection, -analysis, -modeling, and -validation
Knowledge representation and Reasoning
Types of CPDsNoisy-Or CPD– common for medical diagnosis applications Sigmoid CPD – best design approach (personal opinion)
15
2.9 Circuit design and Noisy-OR
04/15/23 Amos Otieno Olwendo 16
3.1 METHODOLOGY
Non-interventional(Observational) retrospective study [Experimental study]
Conducted at Loghman Hakim: Heart &Lung Division
Tehran- a city with high levels of air pollution (especially during winter )
17
3.2 Methodology
This study was conducted from August 2013 to January 2014
This unit receives approximately 420 COPD patients and 4200 Asthma patients monthly
18
3.3 Methodology Sample Size: 100 COPD + 100 Asthma
The environment composed of Dr. Agin, 2 resident physicians (worked with Dr. Agin), and 2 nurses (1 translator + Dr. Agin-Patient contact) Amos
conducted a structured interviews and data was recorded using
a structured checklist19
3.4 Initial BN Design
04/15/23 Amos Otieno Olwendo 20
3.5 Checklist The checklist had 10 questions Parameter measures were conducted through
self report and/or Observation
Checklist design patients had to commit to their parameter
choices by choosing a number between 0 and 10
Each interview result was cross -checked with the reference standards
21
3.6 COPD & Asthma Diagnosis
Patient History History of present illness Past medical history Family history of COPD and Asthma social history of the patient (exposure to irritants)
Physical Exam Review of systems Visual examination (include palpation and percussion) listing to the lungs (stethoscope), physical activity
22
3.7 COPD & Asthma Diagnosis
Pulmonary Function Test(PFT)s e.g. spirometry / Bronchodilators (Nebulizer)
X-ray – if necessary
Vital signs Examine O2 and CO2 in the blood (pulse oximeter ) Blood pressure (sphygmomanometer exam.)
23
3.8 Data Collection…design
04/15/23 Amos Otieno Olwendo 24
04/15/23 25Amos Otieno Olwendo
3.10 Neural Network setup
04/15/23 Amos Otieno Olwendo 26
3.11 Data Analysis Primary tool: the Bayesian network Model Validation: NN based on LM algorithm The dataset was divided into
60% for training 40% test
To ensure an even distribution and representation, we grouped cases based on phenotypes (per
group: target and control) then assigned identifications to case then
Through simple random sampling, we determined what cases to be used for training and testing respectively
27
3.12 Data Analysis
Developed a C++ application – through cases analysis, assigns a real number between negative and
positive infinity to each patient case (using MLE)
loaded these results to SQL Server and R Statistical software to obtain graphical
outputs
28
3.13 Reliability Analysis: SPSS
04/15/23 Amos Otieno Olwendo 29
3.14 Reliability Analysis: SPSS
04/15/23 Amos Otieno Olwendo 30
4.1 RESULTS: BNBayesian Network Classification of 40 COPD Test Cases
COPD Phenotype Number of Cases
Asthma 1
Asthmatic COPD 5
Chronic bronchitis 13
General COPD 21
04/15/23 Amos Otieno Olwendo 31
4.2 RESULTS: BN
Bayesian Network Classification of 40 Asthma Test Cases
Classification Number of Cases
Asthma 34
Asthmatic COPD 6
32
4.3 RESULTS: NNLevenberg-Marquardt Algorithm Classification of 40 COPD
Test Cases
COPD Phenotype Number of Cases
Asthma 2
Asthmatic COPD 2
Chronic bronchitis 25
General COPD 10
None 1
33
4.4 RESULTS: NN
Levenberg-Marquardt Classification of 40 Asthma Test Cases
Classification Number of Cases
Asthma 34
Asthmatic COPD 6
34
4.5 RESULTS: Summary
35
Category Bayesian Network Percentage (%)
Classification of the Test Data Set
Levenberg-Marquardt Algorithm)
Percentage (%) Classification of
the Test Data Set
COPD 97.50 92.50
Asthma 100 100
Overall 98.75 96.25
4.6 RESULTS : C++ (MLE)
36
4.7 RESULTS: C++(group plot)
37
4.8 RESULTS: C++
38
5.1 DISCUSSION1. COPD burden worldwide is underestimated
(could be worse than it is)2. COPD under-diagnosis and/or misdiagnosis should
not pose the challenges it currently does to clinicians
3. Increasing cases of COPD could be as 3.1 a result of the changes in some social behaviors
that3.2 affect COPD development and progression3.3 Such behavior may include:
3.3.1 increasing number of female smokers and 3.3.2 increasing number of teenage smokers
4. Worst hit populations are in middle to low-income countries (inadequate healthcare services) 39
5.2 SUGGESTIONS
1. Increased COPD Awareness at the community level
1.1 Anti-smoking campaigns1.2 Reduced exposure to 2nd hand cigarette smoke
(creation of designated smoking areas)1.3 Cooking using firewood/cow dung in less
ventilated environments1.4 Air obstruction symptoms1.5 Legal measures- who can smoke and or buy
cigarettes40
5.3 SUGGESTIONS2. Population-based screening (“Target Case
Finding”)2.1 whenever an individual shows up to a health
care worker2.2 Maybe useful in identifying those at risk
3. Need for screening devices since 3.1 certain localities lack specialist and/or 3.2 equipment (PFT devices, other test materials
like bronchodilators, X-ray machines, maybe computers and or internet)
41
5.4 SUGGESTIONS : Screening Criteria
42
End! Thank you
04/15/23 43Amos Otieno Olwendo